首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay.
【2h】

Quantitation of human immunodeficiency virus type 1 DNA and RNA by a novel internally controlled PCR assay.

机译:通过新型内部控制的PCR分析定量人类1型免疫缺陷病毒的DNA和RNA。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A novel internally controlled PCR (ICPCR) assay was developed to accurately quantitate human immunodeficiency virus type 1 (HIV-1) DNA and RNA in peripheral blood mononuclear cells and plasma. The ICPCR assay was sensitive and reproducible within a linear range of amplification of 10(0) to 10(3) copies for HIV-1 DNA and 10(1) to 10(4) copies for HIV-1 RNA. The assay detected HIV-1 RNA in plasma and peripheral blood mononuclear cells from all HIV-1 subjects regardless of disease stage. ICPCR was compared with a branched-DNA signal amplification assay for subjects beginning antiretroviral therapy. The reductions in plasma HIV-1 RNA in response to therapy were comparable with the two assays. The ICPCR assay should be useful in monitoring HIV-1 RNA levels both in natural history studies and in clinical trials of antiretroviral agents.
机译:开发了一种新型的内部控制PCR(ICPCR)分析方法,以准确定量外周血单核细胞和血浆中的人类1型免疫缺陷病毒(HIV-1)DNA和RNA。 ICPCR分析在HIV-1 DNA扩增10(0)至10(3)拷贝和HIV-1 RNA 10(1)至10(4)拷贝的线性扩增范围内是灵敏且可重复的。该测定法检测了所有HIV-1受试者血浆和外周血单个核细胞中的HIV-1 RNA,而与疾病阶段无关。对于开始抗逆转录病毒治疗的受试者,将ICPCR与分支DNA信号放大分析进行了比较。响应治疗,血浆HIV-1 RNA的减少与两种检测方法相当。 ICPCR测定法在自然史研究和抗逆转录病毒药物的临床试验中均应用于监测HIV-1 RNA水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号